DelMar Pharmaceuticals to Present New Pre-clinical Data Related to the Mechanism of VAL-083 at the AACR Annual Meeting in April 2012

Feb 7, 2012

DelMar Pharmaceuticals Granted U.S. Orphan Drug Designation for VAL-083 for the Treatment of Glioma

Feb 2, 2012

DelMar Pharmaceuticals Initiates Glioblastoma Clinical Trial

Oct 25, 2011

DelMar Pharmaceuticals Receives FDA IND Approval to Begin Clinical Trials with a New Brain Cancer Treatment

Sep 6, 2011

DelMar pharmaceuticals to Present at 2nd World Orphan Drugs Summit

Aug 23, 2011

DelMar Pharmaceuticals Selected to Present at 10th Annual BIO Investor Forum

Aug 16, 2011

DelMar Pharma Receives Funding Support from National Research Council of Canada

Aug 2, 2011

DelMar Pharma Invited to Present at Leading Life Sciences Conference

Feb 18, 2011

DelMar Pharmaceuticals to present at BioContact Québec

Oct 5, 2010